EP2850101
And-FCRN-mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.5.2013EP published:
1.5.2019EP application number:
13725298.7
EP translation filed:
28.6.2019Grant published:
15.8.2019EPO information:
European Patent Register
Max expiry date:
12.5.2033Expiry date:
12.5.2026Next due date:
31.5.2026
Title:
ANTI-FCRN ANTIBODIES
Timeline
Today
13.5.2013EP application
1.5.2019EP Publication
28.6.2019Translation submitted
15.8.2019Registration published
12.5.2026Expires
Owner
Name:
UCB Biopharma SRLAddress:
Allé de la Recherche 60, 1070 Brussels, BE
Inventor
Name:
FINNEY, Helene MargaretAddress:
SloughBerkshire SL1 3WE, GB
Name:
LAWSON, Alastair David GriffithsAddress:
SloughBerkshire SL1 3WE, GB
Name:
SHAW, Stevan GrahamAddress:
SloughBerkshire SL1 3WE, GB
Name:
SMITH, Bryan JohnAddress:
SloughBerkshire SL1 3WE, GB
Name:
TYSON, Kerry LouiseAddress:
SloughBerkshire SL1 3WE, GB
Name:
KEVORKIAN, LaraAddress:
SloughBerkshire SL1 3WE, GB
Name:
MEIER, ChristophAddress:
SloughBerkshire SL1 3WE, GB
Name:
ATHERFOLD, Paul, AlanAddress:
SloughBerkshire SL1 3WE, GB
Name:
SARKAR, KaushikAddress:
SloughBerkshire SL1 3WE, GB
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201208370Date:
14.5.2012Country:
GB
Supplementary protection
SPC number:
SPC464
Classification
Categories:
C07K 16/28, G01N 33/53
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 27.6.2019
Expires: 12.5.2020
Payer: Tego ehf.
Number: 8
Paid: 7.4.2020
Expires: 12.5.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.4.2021
Expires: 12.5.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 5.4.2022
Expires: 12.5.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 12.4.2023
Expires: 12.5.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.4.2024
Expires: 12.5.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.5.2025
Expires: 12.5.2026
Payer: Árnason Faktor ehf.